$28.580
+0.760 (+2.66%)Al cierre
Noticias de PGNY
Eventos de PGNY
Progyny Anticipates 1.2 Million New Covered Lives in 2027
Progyny earlier revealed insights from the company's current annual selling season, based on both commitments received to date and anticipated remaining decisions which are expected to contribute 1.2 million new covered lives from launches throughout the first half of 2027. "With the commitments we have received to date and anticipated remaining decisions, our selling season is pacing to a potential record level for new lives added for our managed fertility solution," said Pete Anevski, CEO, Progyny. "We believe it isn't coincidental that we're seeing these strong results given the expected record increases in the overall medical plan cost in 2027."
Sees Q3 Revenue of $335M-$345M
Sees Q3 revenue $335M-$345M, consensus $350.57M. Sees Q3 adjusted EBITDA $56M-$59M.
Progyny Reports Q2 Revenue of $350.51M
Reports Q2 revenue $350.51M, consensus $348.65M. "The strong second quarter results reflect that member engagement trended to the higher end of our expectations, as members continued to pursue the services they need in order to address their family building and overall health and well-being goals," said Pete Anevski, Chief Executive Officer of Progyny.
Company Raises FY26 Revenue Outlook to $1.36B-$1.39B
Consensus $2.06. Raises FY26 revenue view to $1.36B-$1.39B from $1.37B-$1.41B, consensus $1.38B. Narrows FY26 adjusted EBITDA view to $233M-$240M from $232M-$244M. The company said, "Member engagement typically lessens during the peak of the summer months, and the third quarter guidance reflects a slightly more pronounced seasonal impact on member activity. With our present visibility, activity in September is consistent with the engagement seen over the first half of the year, and this is reflected in the assumptions for the remainder of the year."
Progyny Approves $200 Million Share Repurchase Program
Progyny announced that its Board of Directors has approved a share repurchase program to repurchase up to $200 million of its common stock. The program will be funded through available cash balances.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.